PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
+13.1%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$289M
AUM Growth
+$93.9M
(+48%)
Cap. Flow
+$84.1M
Cap. Flow
% of AUM
29.12%
Top 10 Holdings %
Top 10 Hldgs %
31.45%
Holding
95
New
31
Increased
23
Reduced
9
Closed
17
Top Buys
| 1 |
Exact Sciences
EXAS
|
$8.27M |
| 2 |
GSK
GSK
|
$8.25M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$8.18M |
| 4 |
Centene
CNC
|
$7.73M |
| 5 |
Revvity
RVTY
|
$6.94M |
Top Sells
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
$9.99M |
| 2 |
iShares Europe ETF
IEV
|
$7.22M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
$7.07M |
| 4 |
Humana
HUM
|
$6.84M |
| 5 |
AET
Aetna Inc
AET
|
$4.84M |
Sector Composition
| 1 | Healthcare | 86.67% |
| 2 | Financials | 0% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| $5.45M | 1.61% |
175,000
+35,000
| +25% | +$1.09M |
|
27
Eli Lilly
LLY
$652B
| $5.4M | 1.6% |
+64,250
| New | +$5.4M |
|
28
Supernus Pharmaceuticals
SUPN
$2.58B
| $5.4M | 1.6% |
172,500
+117,500
| +214% | +$3.68M |
|
29
AbbVie
ABBV
$375B
| $5.38M | 1.59% |
82,625
-67,750
| -45% | -$4.41M |
|
30
Penumbra
PEN
$11B
| $5.22M | 1.54% |
62,555
-32,445
| -34% | -$2.71M |
|
|
QGENF
31
DELISTED
QIAGEN NV
QGENF
| $4.42M | 1.31% |
+152,500
| New | +$4.42M |
|
32
Medpace
MEDP
$13.7B
| $4.34M | 1.28% |
145,282
+42,775
| +42% | +$1.28M |
|
|
SIEN
33
DELISTED
Sientra, Inc.
SIEN
| $4.25M | 1.26% |
50,480
+480
| +1% | +$40.4K |
|
34
Insulet
PODD
$24.5B
| $4.19M | 1.24% |
+97,256
| New | +$4.19M |
|
|
KTWO
35
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.16M | 1.23% |
202,907
-39,293
| -16% | -$806K |
|
|
ADMS
36
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $4.16M | 1.23% |
+237,500
| New | +$4.16M |
|
37
Teva Pharmaceuticals
TEVA
$21.7B
| $4.01M | 1.19% |
+124,875
| New | +$4.01M |
|
|
IMMU
38
DELISTED
Immunomedics Inc
IMMU
| $3.53M | 1.04% |
545,000
+208,500
| +62% | +$1.35M |
|
39
Accuray
ARAY
$170M
| $3.25M | 0.96% |
685,100
+386,307
| +129% | +$1.83M |
|
40
DexCom
DXCM
$31.6B
| $2.97M | 0.88% |
+140,000
| New | +$2.97M |
|
|
NSTG
41
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.84M | 0.84% |
142,750
-18,561
| -12% | -$369K |
|
|
NDRM
42
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $2.76M | 0.82% |
103,850
+23,667
| +30% | +$628K |
|
|
GBT
43
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.23M | 0.66% |
+60,598
| New | +$2.23M |
|
44
Collegium Pharmaceutical
COLL
$1.21B
| $2.01M | 0.6% |
+200,000
| New | +$2.01M |
|
|
ARRY
45
DELISTED
Array Biopharma Inc
ARRY
| $1.99M | 0.59% |
223,000
+65,640
| +42% | +$587K |
|
|
CLVS
46
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.99M | 0.59% |
+31,250
| New | +$1.99M |
|
47
Pacira BioSciences
PCRX
$1.19B
| $1.94M | 0.57% |
+42,500
| New | +$1.94M |
|
|
OTIC
48
DELISTED
Otonomy, Inc.
OTIC
| $1.68M | 0.5% |
+137,500
| New | +$1.68M |
|
|
AIMT
49
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.52M | 0.45% |
+70,000
| New | +$1.52M |
|
50
Jazz Pharmaceuticals
JAZZ
$7.86B
| $1.48M | 0.44% |
+10,200
| New | +$1.48M |
|